Related Experiment Video
Updated: May 31, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
HIV-1 matrix protein binding to RNA
Ayna Alfadhli1, Henry McNett, Seyram Tsagli
1Vollum Institute and Department of Microbiology, Oregon Health and Science University, Portland, OR 97201-3098, USA. alfadhli@ohsu.edu
Abstract:
The matrix (MA) domain of the human immunodeficiency virus type 1 (HIV-1) precursor Gag (PrGag) protein plays multiple roles in the viral replication cycle. One essential role is to target PrGag proteins to their lipid raft-associated phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P(2)] assembly sites at the plasma membranes of infected cells. In addition to this role, several reports have implicated nucleic acid binding properties to retroviral MAs. Evidence indicates that RNA binding enhances the binding specificity of MA to PI(4,5)P(2)-containing membranes and supports a hypothesis in which RNA binding to MA acts as a chaperone that protects MA from associating with inappropriate cellular membranes prior to PrGag delivery to plasma membrane assembly sites. To gain a better understanding of HIV-1 MA-RNA interactions, we have analyzed the interaction of HIV MA with RNA ligands that were selected previously for their high affinities to MA. Binding interactions were characterized via bead binding, fluorescence anisotropy, gel shift, and analytical ultracentrifugation methods. Moreover, MA residues that are involved in RNA binding were identified from NMR chemical shift data. Our results indicate that the MA RNA and PI(4,5)P(2) binding sites overlap and suggest models for Gag-membrane and Gag-RNA interactions and for the HIV assembly pathway.
Insights
The matrix (MA) domain of HIV-1 Gag protein binds RNA and phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P(2)]. RNA binding enhances MA specificity for PI(4,5)P(2) membranes, guiding viral assembly.
Area of Science:
- Virology
- Molecular Biology
- Structural Biology
Background:
- The matrix (MA) domain of human immunodeficiency virus type 1 (HIV-1) precursor Gag (PrGag) protein is crucial for viral replication.
- MA targets PrGag to specific membrane sites, interacting with phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P(2)].
- MA exhibits nucleic acid binding properties, potentially influencing its membrane targeting and specificity.
Purpose of the Study:
- To investigate the interaction between HIV-1 MA and RNA ligands.
- To understand how RNA binding affects MA's interaction with PI(4,5)P(2)-containing membranes.
- To elucidate the structural basis of HIV-1 MA-RNA interactions.
Main Methods:
- Bead binding assays
- Fluorescence anisotropy
- Gel shift assays
- Analytical ultracentrifugation
- Nuclear Magnetic Resonance (NMR) chemical shift analysis
Main Results:
- HIV-1 MA binds to specific RNA ligands with high affinity.
- The binding sites for MA on RNA and PI(4,5)P(2) overlap.
- NMR data identified specific MA residues involved in RNA binding.
Conclusions:
- RNA binding acts as a chaperone, enhancing MA specificity for target membranes.
- Overlapping binding sites suggest a coordinated mechanism for Gag-membrane and Gag-RNA interactions.
- Findings provide insights into the HIV assembly pathway and potential therapeutic targets.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Viruses with RNA Genomes
Size and Structure of Viral Genomes
Retrovirus Life Cycles
Inhibitors Of Virion Release
Leaky Scanning

